Loading...
Loading...
Among the 3 tracked institutional investors we monitor, COEP (COEPTIS THERAPEUTICS HLDGS I) is held with a combined value of $5.29M across 379,882 shares. The largest holder is VANGUARD GROUP INC with a position worth $4.84M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 2 funds reduced their position.
Total Institutional Value
$5.29M
Total Shares Held
379,882
Institutional Holders
3
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $4.84M | 0.00% | New |
| 2 | STATE STREET CORP | $301.03K | 0.00% | - |
| 3 | BlackRock, Inc. | $152.21K | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of COEP with a position worth $4.84M, representing 0.00% of their portfolio. In total, 3 institutional investors hold COEP with a combined value of $5.29M.
In the most recent quarter, 1 fund opened a new position in COEP. Additionally, 2 reduced their positions.
Institutional investors hold $5.29M worth of COEP stock across 3 positions. The largest institutional holder is VANGUARD GROUP INC with $4.84M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For COEP, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their COEP positions.